Basic data related to thrombolytic therapy for acute venous thrombosis

Tina T Ng1, Michael Sigman1, Fred A Weaver1

  • 1Division of Vascular Surgery and Endovascular Therapy, USC Cardiovascular Thoracic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Insights

Current treatment guidelines for iliofemoral deep venous thrombosis (DVT) lack robust data. This review summarizes existing evidence on catheter-directed thrombolysis (CDT) and pharmacomechanical thrombectomy to inform future DVT management strategies.

Area of Science:

  • Vascular Medicine
  • Interventional Cardiology
  • Thrombosis Research

Background:

  • Treatment guidelines for iliofemoral deep venous thrombosis (DVT) are based on limited observational and prospective studies.
  • The ATTRACT trial is the first large, multicenter randomized control trial for iliofemoral DVT treatment strategies.
  • Existing data on catheter-directed thrombolysis (CDT) and pharmacomechanical thrombectomy for acute iliofemoral DVT are limited.

Purpose of the Study:

  • To summarize existing data informing the use of catheter-directed thrombolysis (CDT) or pharmacomechanical thrombectomy.
  • To provide a foundation for understanding current treatment strategies in acute iliofemoral DVT.
  • To contextualize the upcoming results from the ATTRACT trial.

Main Methods:

  • A comprehensive literature search was conducted using PubMed, Ovid, and Cochrane databases.
  • Searched for articles published up to December 2013.
  • Included studies with at least 25 patients, case series, national registry data, and randomized control trials.

Main Results:

  • Nineteen case series (1996-2012) and three national registry studies were identified.
  • Treatment modalities included anticoagulation, surgical thrombectomy, pharmacomechanical thrombectomy, and CDT.
  • Only two randomized control trials (2002-2012) were found, both supporting CDT over anticoagulation alone for iliofemoral DVT.

Conclusions:

  • Current treatment guidelines for acute iliofemoral DVT are based on limited clinical data.
  • The evidence base for CDT and pharmacomechanical thrombectomy in iliofemoral DVT requires further robust investigation.
  • This summary anticipates the findings of the ongoing ATTRACT trial to refine DVT treatment guidelines.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749